Knight Therapeutics Pink Sheet Forecast - Naive Prediction
| KHTRF Stock | USD 4.26 0.07 1.67% |
Knight Pink Sheet outlook is based on your current time horizon. We recommend always using this module together with an analysis of Knight Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 26th of January 2026, the relative strength index (RSI) of Knight Therapeutics' share price is approaching 47. This indicates that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Knight Therapeutics, making its price go up or down. Momentum 47
Impartial
Oversold | Overbought |
Using Knight Therapeutics hype-based prediction, you can estimate the value of Knight Therapeutics from the perspective of Knight Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Knight Therapeutics on the next trading day is expected to be 4.19 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.94. Knight Therapeutics after-hype prediction price | USD 4.27 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Knight |
Knight Therapeutics Additional Predictive Modules
Most predictive techniques to examine Knight price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Knight using various technical indicators. When you analyze Knight charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Knight Therapeutics Naive Prediction Price Forecast For the 27th of January
Given 90 days horizon, the Naive Prediction forecasted value of Knight Therapeutics on the next trading day is expected to be 4.19 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.94.Please note that although there have been many attempts to predict Knight Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Knight Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Knight Therapeutics Pink Sheet Forecast Pattern
| Backtest Knight Therapeutics | Knight Therapeutics Price Prediction | Buy or Sell Advice |
Knight Therapeutics Forecasted Value
In the context of forecasting Knight Therapeutics' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Knight Therapeutics' downside and upside margins for the forecasting period are 3.44 and 4.94, respectively. We have considered Knight Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Knight Therapeutics pink sheet data series using in forecasting. Note that when a statistical model is used to represent Knight Therapeutics pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.7816 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0317 |
| MAPE | Mean absolute percentage error | 0.0074 |
| SAE | Sum of the absolute errors | 1.9358 |
Predictive Modules for Knight Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Knight Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Knight Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Knight Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Knight Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Knight Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Knight Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Knight Therapeutics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Knight Therapeutics' historical news coverage. Knight Therapeutics' after-hype downside and upside margins for the prediction period are 3.52 and 5.02, respectively. We have considered Knight Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Knight Therapeutics is not too volatile at this time. Analysis and calculation of next after-hype price of Knight Therapeutics is based on 3 months time horizon.
Knight Therapeutics Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Knight Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Knight Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Knight Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.03 | 0.75 | 0.01 | 0.01 | 3 Events / Month | 4 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
4.26 | 4.27 | 0.23 |
|
Knight Therapeutics Hype Timeline
Knight Therapeutics is now traded for 4.26. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.01. Knight is projected to increase in value after the next headline, with the price projected to jump to 4.27 or above. The average volatility of media hype impact on the company the price is over 100%. The price rise on the next news is estimated to be 0.23%, whereas the daily expected return is now at 0.03%. The volatility of related hype on Knight Therapeutics is about 306.12%, with the expected price after the next announcement by competition of 4.27. The company reported the revenue of 243.48 M. Net Income was 15.68 M with profit before overhead, payroll, taxes, and interest of 115.41 M. Assuming the 90 days horizon the next projected press release will be in about 3 days. Check out Historical Fundamental Analysis of Knight Therapeutics to cross-verify your projections.Knight Therapeutics Related Hype Analysis
Having access to credible news sources related to Knight Therapeutics' direct competition is more important than ever and may enhance your ability to predict Knight Therapeutics' future price movements. Getting to know how Knight Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Knight Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HUMDF | Hua Medicine | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CRLBF | Cresco Labs | 0.35 | 9 per month | 8.21 | 0.05 | 14.49 | (10.00) | 120.83 | |
| VRNOF | Verano Holdings Corp | 0.35 | 12 per month | 9.01 | 0.04 | 13.79 | (11.46) | 116.00 | |
| PTCHF | PureTech Health plc | 0.35 | 8 per month | 0.00 | 0.05 | 3.53 | 0.00 | 7.74 | |
| SUSRF | Surgical Science Sweden | 0.00 | 0 per month | 0.00 | (0.15) | 0.59 | (2.40) | 60.80 | |
| AGYTF | Allergy Therapeutics plc | 0.35 | 3 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AVCTF | Avacta Group Plc | 0.35 | 6 per month | 0.00 | (0.14) | 1.03 | (5.13) | 35.79 | |
| CLHLF | COLTENE Holding AG | 0.35 | 6 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VHIBF | Vitalhub Corp | 0.35 | 22 per month | 0.00 | (0.07) | 3.98 | (5.47) | 14.12 | |
| BOVNF | BioInvent International AB | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for Knight Therapeutics
For every potential investor in Knight, whether a beginner or expert, Knight Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Knight Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Knight. Basic forecasting techniques help filter out the noise by identifying Knight Therapeutics' price trends.Knight Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Knight Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Knight Therapeutics could also be used in its relative valuation, which is a method of valuing Knight Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Knight Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Knight Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Knight Therapeutics shares will generate the highest return on investment. By undertsting and applying Knight Therapeutics pink sheet market strength indicators, traders can identify Knight Therapeutics entry and exit signals to maximize returns.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 4.26 | |||
| Day Typical Price | 4.26 | |||
| Price Action Indicator | 0.035 | |||
| Period Momentum Indicator | 0.07 | |||
| Relative Strength Index | 47.35 |
Knight Therapeutics Risk Indicators
The analysis of Knight Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Knight Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting knight pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.3631 | |||
| Semi Deviation | 0.4147 | |||
| Standard Deviation | 0.7301 | |||
| Variance | 0.5331 | |||
| Downside Variance | 1.0 | |||
| Semi Variance | 0.172 | |||
| Expected Short fall | (1.12) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Knight Therapeutics
The number of cover stories for Knight Therapeutics depends on current market conditions and Knight Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Knight Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Knight Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Knight Pink Sheet
Knight Therapeutics financial ratios help investors to determine whether Knight Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Knight with respect to the benefits of owning Knight Therapeutics security.